Structural Formula (Egr00 0001 01)
Egrifta Wr Kit
Product Images NDC 62064-381
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 58 technical images submitted to the FDA as part of the official labeling for Egrifta Wr (NDC 62064-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Theratechnologies Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Egr00 0001 02)
This text appears to be a table showing patient (age) data for two different studies. The studies compare the effectiveness of a treatment (potentially a placebo or tesamorelin) on changing belly appearance distress in patients. The data seems to be presented in percentages.*
Figure 2 (Egr00 0001 03)
Thera Technologies (Egr00 0001 04)
Thera Patient Support (Egr00 0001 05)
Medication Box (Egr00 0001 06)
Injection Box (Egr00 0001 07)
This text provides information about an INJECTION BOX intended for use with a specific medication called EGRIFTA WR (tesamorelin) for injection, at a dose of 11.6 mg/vial. It mentions the new formulation, dose, mixing instructions, and storage details, stating that one mixed vial provides daily doses for seven days. The text emphasizes the need to have the EGRIFTA WR 11.6 mg vial MEDICATION BOX in addition to the INJECTION BOX. It also cautions that Bacteriostatic Water for Injection USP contains benzyl alcohol as a preservative. The contents of the INJECTION BOX are described as non-substitutable. Additionally, the text lists the components of the box, which include multiple-dose Bacteriostatic Water, syringes, alcohol swabs, and storage instructions.*
Figure A (Egr00 0001 08)
Additional supplies required for a medical procedure include a gauze pad, adhesive bandage, and a sharps disposal container. These items are essential for wound care and safe disposal of medical sharp objects. Refer to Figure A for visual guidance.*
Figure B (Egr00 0001 09)
This description provides information about a medication box containing a vial of EGRIFTAWR 116 mg and an injection box with a 3 mL bottle of Bacteriostatic Water, a syringe with a needle for injection attached (clear cap), and an alcohol swab. The figure B may also be illustrating the contents.*
Figure C (Egr00 0001 10)
Figure D (Egr00 0001 11)
Figure E (Egr00 0001 12)
Figure F (Egr00 0001 13)
This text mentions "Bacteriostatic Water for Injection". Bacteriostatic water is a type of water that is used to dilute or dissolve medications for injection. It contains an added preservative to prevent the growth of bacteria in the water. It is typically used for reconstituting medications such as peptides, growth hormone, and other substances that need to be diluted before injection.*
Figure G (Egr00 0001 14)
Figure H (Egr00 0001 15)
Figure I (Egr00 0001 16)
Figure J (Egr00 0001 17)
Figure K (Egr00 0001 18)
Figure L (Egr00 0001 19)
Figure M (Egr00 0001 20)
Figure N (Egr00 0001 21)
This description is about a tiny air bubble which is considered normal in the given context. The text also mentions a measurement of 1% (1.5 mL) and a figure labeled as "Figure N".*
Figure O (Egr00 0001 22)
Figure P (Egr00 0001 23)
Figure Q (Egr00 0001 24)
Figure R (Egr00 0001 25)
This is a label for an "Injection Box" containing "Bacteriostatic Water for Injection". The label also includes a reference to "Figure R".*
Figure S (Egr00 0001 26)
Figure T (Egr00 0001 27)
Figure U (Egr00 0001 28)
Figure V (Egr00 0001 29)
Figure W (Egr00 0001 30)
Figure X (Egr00 0001 31)
This text describes a medication box containing a mixed and clear solution from weekly mixing and an injection box with BD SafetyGlide™ syringe with a needle attached (orange cap) and alcohol swabs. The provided items seem to be used for administering injections or medications.*
Figure Y (Egr00 0001 32)
Figure Z (Egr00 0001 33)
Figure Aa (Egr00 0001 34)
Figure Ab (Egr00 0001 35)
Figure Ac (Egr00 0001 36)
Figure Ad (Egr00 0001 37)
Figure Ae (Egr00 0001 38)
Figure Af (Egr00 0001 39)
Figure Ag (Egr00 0001 40)
Figure Ah (Egr00 0001 41)
Figure Ai (Egr00 0001 42)
Figure Aj (Egr00 0001 43)
Figure Ak (Egr00 0001 44)
Figure Al (Egr00 0001 45)
Figure Am (Egr00 0001 46)
Figure An (Egr00 0001 47)
Figure Ao (Egr00 0001 48)
Figure Ap (Egr00 0001 49)
Figure Aq (Egr00 0001 50)
Figure Ar (Egr00 0001 51)
Figure As (Egr00 0001 52)
Figure At (Egr00 0001 53)
Figure Au (Egr00 0001 54)
Figure Av (Egr00 0001 55)
Medication Box (Egr00 0001 56)
This is a medication guide for EGRIFTA WR™ (tesamorelin) for injection. The text provides detailed instructions on how to mix and administer the medication, its recommended dose, storage instructions, and contact information for assistance or to report side effects. It emphasizes the importance of following the prescribed dose and proper mixing procedures for subcutaneous use. The medication is supplied in a sterile lyophilized powder form and must be mixed with specified volumes of Bacteriostatic Water for Injection USP. It also includes information on the formulation, dosage, and storage requirements. Users are encouraged to refer to the provided injection box for additional instructions and to contact healthcare providers or patient support if needed.*
Injection Box (no warning)
This is a product description for an Injection Box containing items for use with EGRIFTAWR (tesamorelin) for injection 11.6 mg/vial. The box includes instructions for use, Bacteriostatic Water for Injection, syringes with needles, and alcohol swabs. It is important to note that this Injection Box does not contain the medication itself, so one must also have the EGRIFTAWR 11.6 mg/vial Medication Box to proceed. Mixing instructions and storage information are provided, specifying that the product should be stored at room temperature. It emphasizes that EGRIFTAWR and EGRIFTA SV are not interchangeable. For more details on weekly mixing and daily injections, one should refer to the Instructions for Use included in the box.*
Vial (Egr00 0001 60)
This text contains information about EGRIFTA WR, which is a medication (tesamorelin) for injection. It is stored at a temperature range of 20°C to 25°C and is for subcutaneous use. The recommended daily dose is 1.28 mg (0.16 mL), and it is provided in single-patient-use vials. The manufacturer is Theratechnologies Inc. with a U.S. License No. 2091.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
